The interaction of selenium with chemotherapy and radiation on normal and malignant human mononuclear blood cells

28Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Selenium, a trace element with anticancer properties, can reduce harmful toxicities of chemotherapy and radiotherapy without compromising efficacy. However, the dose-response relationship in normal versus malignant human cells is unclear. We evaluated how methylseleninic acid (MSA) modulates the toxicity and efficacy of chemotherapy and radiation on malignant and non-malignant human mononuclear blood cells in vitro. We specifically investigated its effects on endoplasmic reticulum stress induction, intracellular glutathione concentration, DNA damage and viability of peripheral blood mononuclear cells and THP1 monocytic leukaemia cells in response to radiation, cytosine arabinoside or doxorubicin chemotherapy. MSA, at lower concentrations, induced protective responses in normal cells but cytotoxic effects in malignant cells, alone and in conjunction with chemotherapy or radiation. However, in normal cells higher concentrations of MSA were directly toxic and increased the cytotoxicity of radiation but not chemotherapy. In malignant cells higher MSA concentrations were generally more effective in combination with cancer treatments. Thus, optimal MSA concentrations differed between normal and malignant cells and treatments. This work supports clinical reports that selenium can significantly reduce dose-limiting toxicities of anticancer therapies and potentially improve efficacy of anticancer treatments. The optimal selenium compound and dose is not yet determined.

References Powered by Scopus

Selenium and human health

2746Citations
N/AReaders
Get full text

The comet assay for DNA damage and repair: Principles, applications, and limitations

2412Citations
N/AReaders
Get full text

Endoplasmic reticulum stress and oxidative stress: A vicious cycle or a double-edged sword?

1353Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Selenium and selenoproteins: it’s role in regulation of inflammation

414Citations
N/AReaders
Get full text

Selenium species: Current status and potentials in cancer prevention and therapy

166Citations
N/AReaders
Get full text

An update on the mechanisms related to cell death and toxicity of doxorubicin and the protective role of nutrients

87Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lobb, R. J., Jacobson, G. M., Cursons, R. T., & Jameson, M. B. (2018). The interaction of selenium with chemotherapy and radiation on normal and malignant human mononuclear blood cells. International Journal of Molecular Sciences, 19(10). https://doi.org/10.3390/ijms19103167

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 12

67%

Researcher 4

22%

Professor / Associate Prof. 1

6%

Lecturer / Post doc 1

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

38%

Agricultural and Biological Sciences 3

23%

Biochemistry, Genetics and Molecular Bi... 3

23%

Pharmacology, Toxicology and Pharmaceut... 2

15%

Save time finding and organizing research with Mendeley

Sign up for free